Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001465
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
1999-11-03
Brief Title:
Study of the Disease Process of Lymphangioleiomyomatosis
Sponsor:
National Heart Lung and Blood Institute NHLBI
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Characterization of the Pathogenesis of Lymphangioleiomyomatosis LAM
Status:
RECRUITING
Status Verified Date:
2024-06-20
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Pulmonary lymphangioleiomyomatosis LAM is a destructive lung disease typically affecting women of childbearing age Currently there is no effective therapy for the disease and the prognosis is poor
This study is designed to determine the disease processes involved at the level of cells and molecules in order to develop more effective therapy
Researchers intend to identify the proteins and genes that contribute to the process of lung destruction in affected individuals
This study is designed to determine the disease processes involved at the level of cells and molecules in order to develop more effective therapy
Researchers intend to identify the proteins and genes that contribute to the process of lung destruction in affected individuals
Detailed Description:
Individuals with pulmonary lymphangioleiomyomatosis develop severe destructive lung disease Most of them are females of childbearing age Currently there is no proven effective therapy and the prognosis is variable This study is designed to a define the clinical course of the disease and b elucidate the pathogenesis of the disease at the cellular and molecular levels in order to develop more effective therapy To accomplish this we intend to identify the proteins and genes that contribute to the process of lung destruction in affected individuals
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 95-H-0186 | None | None | None |